Eugia US LLC recalls 500 mg progesterone injections due to glass particles in vials. Affected lots from India manufacturing; stop using if you have this product.
“Eugia Progesterone Injection Recall: Glass Particle Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32579-eugia-progesterone-injection-recall-glass-particle-risk. Based on FDA recall #D-0624-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0624-2024%22&limit=1).
Eugia US LLC recalled Progesterone Injection, USP, 500 mg per 10 mL vials nationwide due to the presence of particulate matter, according to the FDA. The agency announced the voluntary Class II recall on July 26, 2024.
How to tell if you have it
Brand: Eugia
Product: Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only
NDC: 55150-306-10
Lot #: CPR230029A
Quantity: 17,136 vials
The hazard
The recall addresses complaints of a glass particle found in the vial. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Eugia US LLC has 14 other recalls on record since December 28, 2022. Other recent recalls of similar products include Lidocaine injection (May 18, 2026), Gentamicin Injection (May 29, 2025), and Tirofiban Injection (April 21, 2025). Recent recalls for similar injection products include Sun Pharmaceutical DOXOrubin Liposome Injection (May 12, 2026), Fresenius Kabi Tyenne Injection (August 10, 2026), and GE Healthcare Omnipaque 300 mg/mL Injection (March 24, 2026).
How to tell if you have this one
Check for the product name 'Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial'. Look for the lot number CPR230029A on the vial.
Brand
Eugia
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the product name and lot number CPR230029A on the vial.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 12 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0624-2024 (July 26, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0624-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.